← SynDRA
CARACEMIDE
SynDRA canonical compound SYN0000357 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | RRM1 |
| Mechanism of action | ribonucleotide reductase inhibitor |
All known targets
Mechanisms of action (all sources)
- ribonucleotide reductase inhibitor
- ACHE INHIBITOR
Cross-references
Synonyms
- Caracemida
- NSC-253272
- NSC 253272
- NSC253272
- N-Acetyl-N-(methylcarbamoyloxy)-N'-methylurea
- H74F6J185A
- RefChem:123348
- DTXCID50153590
- N-(Methylcarbamoyl)-N-((methylcarbamoyl)oxy)acetamide
- [acetyl(methylcarbamoyl)amino] N-methylcarbamate
- C6H11N3O4
- N-(METHYLCARBAMOYL)ACETAMIDO N-METHYLCARBAMATE
- N-Acetyl-N,O-bis(methylcarbamoyl)hydroxylamine
- Caracemide (USAN)
- CARACEMIDE [USAN]
- Caracemidum [Latin]
- Caracemida [Spanish]
- Caracemidum
- Caracemide [USAN:INN]
- CCRIS 1729
- N-(Methylcarbamoyl)-N-[(methylcarbamoyl)oxy]acetamide
- BRN 5935912
- UNII-H74F6J185A
- N-(Methylcarbamoyl)-N-(methylcarbamoyloxy)acetamid
- MFCD00866397
- CARACEMIDE [INN]
- NCIMech_000225
- CARACEMIDE [MART.]
- SCHEMBL3812
- orb1308496
- GDA42467
- CCG-35357
- EBC-08058
- AKOS006274247
- MS-23021
- NCI60_002035
- DS-006307
- HY-119974
- CS-0078854
Look up CARACEMIDE in the interactive SynDRA portal →